Rephonic
Artwork for Oncology Brothers: Practice-Changing Cancer Discussions

Oncology Brothers: Practice-Changing Cancer Discussions

Oncology Brothers
Multiple Myeloma
Myelofibrosis
Colorectal Cancer
Zanubrutinib
Hepatocellular Carcinoma
FDA
Liver Cancer
Radiation Oncology
Stereotactic Body Radiation Therapy
Triple Negative Breast Cancer
Transarterial Chemoembolization
Interventional Radiology
Racial Disparities
Socioeconomic Disparities
Thrombocytopenia
Anemia
STEM Cell Transplant
Blood Cancers
JAK Inhibitors
MD Anderson Cancer Center

The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and ... more

PublishesTwice weeklyEpisodes100Founded3 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for Oncology Brothers: Practice-Changing Cancer Discussions

Latest Episodes

Welcome to the Oncology Brothers podcast! In this episode, we were joined by Dr. Rutika Mehta, a GI medical oncologist from Weill Cornell. Together, we dived into the current treatment landscape for advanced metastatic gastroesophageal junction (GEJ)... more

In this episode of the Oncology Brothers podcast, we dived deep into the world of antibody drug conjugates (ADCs) in non-small cell lung cancer (NSCLC). We welcomed Dr. Jacob Sands from the Dana-Farber Cancer Institute to discuss the latest ADCs appr... more

Welcome to the Oncology Brothers podcast! In this episode, we welcomed Dr. Neil Iyengar and Dr. Emily Gallagher, to dive deep into the world of PIK3CA and AKT pathway inhibitors for hormone receptor-positive (HR+) metastatic breast cancer.

We discus... more

Welcome to the Oncology Brothers podcast! In this episode, we dived into the complexities of non-malignant hematology, focusing on iron abnormalities—both deficiency and overload. We welcomed Dr. Marina Beltrami from The Ohio State University, who gu... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
ASCO Guidelines
ASCO GuidelinesAmerican Society of Clinical Oncology (ASCO)
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Emily Gallagher
Breast medical oncologist
Mount Sinai Hospital
Episode: Managing Toxicities of PI3K & AKT Inhibitors in Breast Cancer – Drs. Emily Gallagher & Neil Iyengar
Dr. Marina Beltrami
A physician specializing in hematology from The Ohio State University
The Ohio State University
Episode: Challenging Cases of Iron Abnormalities, Anemia or Iron Overload - Dr. Marina Beltrami
Dr. Gilles Salles
An expert in lymphoma from Memorial Sloan Kettering.
Memorial Sloan Kettering
Episode: FDA Approval of Epcoritamab-Rituximab-Lenalidomide for R/R Follicular Lymphoma – Dr. Gilles Salles
David Braun
GU medical oncologist from Yale University
Yale University
Episode: Challenging Cases in Second Line & Beyond Renal Cell Carcinoma (RCC) - Dr. David Braun
Yelena Janjigian
Medical oncologist from Memorial Sloan Kettering and lead author of Matterhorn Study
Memorial Sloan Kettering
Episode: FDA Approval of Durvalumab with FLOT in Resectable Gastric & GEJ: MATTERHORN by Dr. Yelena Janjigian
Adam Brufsky
Leader in medical oncology from UPMC Hillman Cancer Center
UPMC Hillman Cancer Center
Episode: Challenging Cases in Breast Cancer with CDK 4/6 Inhibitors – Drs. Sara Tolaney & Adam Brufsky
Joshua Meeks
A urologist from Northwestern University
Northwestern University
Episode: Challenging Cases in Non-Muscle Invasive Bladder Cancer (NMIBC) – Drs. Shilpa Gupta & Joshua Meeks
Shilpa Gupta
A medical oncologist from Cleveland Clinic
Cleveland Clinic
Episode: Challenging Cases in Non-Muscle Invasive Bladder Cancer (NMIBC) – Drs. Shilpa Gupta & Joshua Meeks
Eunice Wang
Lead author from Roswell Park Comprehensive Cancer Center
Roswell Park Comprehensive Cancer Center
Episode: FDA Approval of Ziftomenib (KOMET-001) in NPM1 mut Acute Myeloid Leukemia (AML) – Dr. Eunice Wang

Hosts

Rahul Gosain
Co-host of the Oncology Brothers Podcast
Rohit Gosain
Co-host of the Oncology Brothers Podcast

Reviews

4.8 out of 5 stars from 86 ratings
  • Excellent Resource

    I regularly listen to this podcast and find it an excellent reference for oncology practice. The speakers consistently provide valuable insights that are both practical and informative. It's a great resource for staying updated and enhancing clinical knowledge.

    Apple Podcasts
    5
    RHJ, MD
    United States5 months ago
  • Insightful, relatable, and essential for anyone in the oncology community

    The Oncology Brothers consistently deliver relevant, easy-to-digest insights on complex data and evolving treatment landscapes. Their ability to break down key updates—especially for those who can't attend every conference—is incredibly valuable. A must-listen for anyone in oncology looking to stay current and connected to the community.

    Apple Podcasts
    5
    OncoScriber
    United States5 months ago
  • Stage IV CRC

    Thank you so much for putting this together! Love the updates of ongoing research! I am the primary caretaker for my 79 year old dad who was diagnosed 6/24 with stage IV CRC MSS KRAS G13D TMB-H, so love your GI updates from ASCO ‘25 and subcutaneous nivo, which we are considering. Hope you do more like bot/bal and neodadjuvant single cycle pembro. Thanks for taking the time to do this!!

    Apple Podcasts
    5
    mama4travel
    United States10 months ago
  • Onc Doc in the communty

    I have been following your content on X/Twitter and now I love that I can access these interviews here. Great work, much appreciated when things are moving so fast in this field.

    Apple Podcasts
    5
    Jimzz24
    United Statesa year ago
  • My go to stay in touch with rapidly evolving field

    Amazing resource! Can’t emphasize enough how resourceful your podcast has been. Wonderful resource for staying uptodate with latest and greatest!

    Love the discussions with the experts which are succinct and yet so informative!

    Apple Podcasts
    5
    aby7623
    United States2 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Feedback highlights the practicality and relevance of the discussions, which help bridge the gap between academic knowledge and community practice.
Listeners commend the podcast for being an excellent resource for keeping up with the rapidly changing oncology field.
The podcast is praised for its concise format, making it easier for busy professionals to stay informed about important updates in cancer treatment.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

FDA Approval of Epcoritamab-Rituximab-Lenalidomide for R/R Follicular Lymphoma – Dr. Gilles Salles
Q: Looking specifically at Epcoritamab and Epcor-FL1, is there any role today for MRD to decide if or when we can stop the treatment?
Currently, we do not routinely monitor MRD for follicular lymphoma; treatment duration is time-limited to one year.
FDA Approval of Epcoritamab-Rituximab-Lenalidomide for R/R Follicular Lymphoma – Dr. Gilles Salles
Q: Gilles, can you share what side effects we have to keep in mind and some clinical pearls around this?
Common side effects include cytokine release syndrome (CRS), which occurs early after drug administration, and is usually manageable with supportive care.
FDA Approval of Epcoritamab-Rituximab-Lenalidomide for R/R Follicular Lymphoma – Dr. Gilles Salles
Q: Can you start us off with the mechanism of action for Epcoritamab and then walk us through the study design for Epcor-FL1?
Epcoritamab is a bispecific antibody that recognizes CD20 on B cells and engages T cells, facilitating the killing of malignant B cells.
Managing Toxicities of PI3K & AKT Inhibitors in Breast Cancer – Drs. Emily Gallagher & Neil Iyengar
Q: How do you manage hyperglycemia in patients taking Inavolisib?
I recommend prophylactic metformin and dietary counseling to help manage carbohydrate intake and prevent hyperglycemia.
Managing Toxicities of PI3K & AKT Inhibitors in Breast Cancer – Drs. Emily Gallagher & Neil Iyengar
Q: What are some of the common side effects that you educate your patients on regarding Inavolisib?
The most common toxicities include hyperglycemia, diarrhea, and rash. It's important to manage these proactively to maintain quality of life.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

Discussions focus on bridging the gap between academic centers and community oncology, providing healthcare professionals with concise insights on the latest developments in cancer treatment. Noteworthy topics of discussion include practice-changing data on common cancers such as breast, prostate, kidney, lung, and gastrointestinal cancers, ensuring that listeners can immediately apply new information in their day-to-day clinical practices. Each episode features short interviews with leading oncologists and hematologists, allowing listeners to stay updated on FDA approvals, treatment algorithms, and oncology conference highlights, all within a manageable timeframe.

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. Two Onc Docs
2. Oncology Today with Dr Neil Love
3. Research To Practice | Oncology Videos
4. ASCO Guidelines
5. ASCO Daily News

How many episodes of this podcast are there?

this podcast launched 3 years ago and published 100 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Emily Gallagher
2. Dr. Marina Beltrami
3. Dr. Gilles Salles
4. David Braun
5. Yelena Janjigian
6. Adam Brufsky
7. Joshua Meeks
8. Shilpa Gupta

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days